Valuation Roche Holding AG London S.E.

Stocks

Market Closed - London S.E. Other stock markets 18:20:00 30/06/2026 +03			5-day change	1st Jan Change
323.90 ^CHF	0.00%		0.00%	-1.29%

06:49pm	Swiss Market Index Ends Lower; Lonza Shares Up	MT
10:33am	ROCHE HOLDINGS AG : Goldman Sachs sticks Neutral	ZD

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	306,810	239,812	197,073	205,191	262,098	265,464	-	-
Change	-	-21.84%	-17.82%	4.12%	27.73%	1.28%	-	-
Enterprise Value (EV) ¹	324,977	255,396	215,772	222,528	278,258	275,921	269,247	261,573
Change	-	-21.41%	-15.51%	3.13%	25.04%	-0.84%	-2.42%	-2.85%
P/E	23.4x	18.9x	17.1x	24.8x	20.5x	17.7x	16.6x	15.3x
PBR	13.2x	8.29x	5.91x	5.67x	7.8x	6.59x	5.56x	4.73x
PEG	-	-3.69x	-2.48x	-0.9x	0.4x	1x	2.4x	1.81x
Capitalization / Revenue	4.89x	3.79x	3.36x	3.39x	4.26x	4.24x	4.08x	3.89x
EV / Revenue	5.17x	4.04x	3.67x	3.68x	4.52x	4.41x	4.13x	3.84x
EV / EBITDA	13.2x	10.2x	9.82x	9.45x	11.3x	10.8x	9.91x	9.09x
EV / EBIT	14.8x	11.5x	11.2x	10.7x	12.7x	12.2x	11.1x	10.2x
EV / FCF	20.7x	19.6x	19.1x	14.5x	23.6x	17.8x	16.5x	14.8x
FCF Yield	4.83%	5.11%	5.23%	6.89%	4.24%	5.63%	6.07%	6.75%
Dividend per Share ²	9.3	9.5	9.6	9.7	9.8	10.01	10.25	10.52
Rate of return	2.45%	3.27%	3.93%	3.8%	2.99%	3.01%	3.08%	3.16%
EPS ²	16.2	15.37	14.31	10.31	16.04	18.77	20.06	21.76
Distribution rate	57.4%	61.8%	67.1%	94.1%	61.1%	53.4%	51.1%	48.4%
Net sales ¹	62,801	63,281	58,716	60,495	61,516	62,543	65,120	68,207
EBITDA ¹	24,692	25,015	21,976	23,538	24,608	25,445	27,156	28,777
EBIT ¹	21,897	22,173	19,240	20,823	21,833	22,564	24,162	25,698
Net income ¹	13,930	12,421	11,498	8,277	12,880	15,213	16,260	17,443
Net Debt ¹	18,167	15,584	18,699	17,337	16,160	10,457	3,783	-3,891
Reference price ²	379.10	290.50	244.50	255.50	328.20	332.80	332.80	332.80
Nbr of stocks (in thousands)	800,952	800,579	798,652	796,789	796,317	795,618	-	-
Announcement Date	2/3/22 A	2/2/23 A	2/1/24 A	1/30/25 A	1/29/26 A	-	-	-

¹CHF in Million²CHF

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	35.95x	13.06x	26.6x	0.55%	1,097B
JOHNSON & JOHNSON	27.63x	6.35x	17.27x	2.06%	622B
ABBVIE INC.	31.37x	7.5x	15.34x	2.72%	449B
ASTRAZENECA PLC	23.74x	4.94x	14.01x	1.76%	294B
NOVARTIS AG	21.75x	5.59x	13.5x	2.83%	286B
NOVO NORDISK A/S	13.9x	5.17x	10.63x	3.6%	213B
AMGEN INC.	23.5x	6.26x	11.01x	2.8%	195B
GILEAD SCIENCES, INC.	-45.11x	5.46x	30.35x	2.57%	157B
PFIZER INC.	11.4x	3.03x	7.39x	7.19%	139B
Average	16.01x	6.37x	16.23x	2.9%	383.49B
Weighted average by Cap.	24.90x	8.20x	18.83x	2.07%